TenderlineUK
Procurement Intelligence
Official OCDS
Find a Tender
complete
Official procurement procedure

Contract for the provision of Histopathology reporting, Urology and Breast MDT

Pathology services
UK
Published value
Not published
Submission deadline Not published
Lots published1
Procurement Executive Summary
AI & Search Synopsis
Generated from official OCDS record
Tenderline Synopsis: Great Western Hospitals NHS Foundation Trust: "Contract for the provision of Histopathology reporting, Urology and Breast MDT". Published status: complete. Published value: Value not published. 1 published lot. Submission deadline not published. See the official notice for participation instructions.
Contracting AuthorityGreat Western Hospitals NHS Foundation TrustScope & CategoriesNot publishedSubmission Window
complete
No deadline published
Submission GatewayDirect notice routeLegal Basis & RegimeStandard procurementEstimated Value (exc. VAT)Not published
Bidder Intelligence · Authority Profile: Great Western Hospitals NHS Foundation Trust
Market Analytics
View Authority Profile →
Derived from OCDS awards & bid statistics
Published history for Great Western Hospitals NHS Foundation Trust. These figures describe retained records, not a forecast of bids or a measure of buyer bias.
Published-to-award variance
Not availableInsufficient comparable data
Requires at least 5 comparable procedures
Competition Density
1Bids / Report
100% of reports have one bid
Supplier ConcentrationNo estimate
Insufficient attributable awardsNo concentration estimate available
Payment Terms
Check noticePublished terms
Payment obligations depend on the applicable regime and contract. Consult the official documents.
Coverage: 7 active published awards; 3 bid reports (which may be per lot). Supplier values exclude multi-supplier awards, frameworks and DPS, and use GBP only. They are published award values, not payments. Published-to-award variance compares single-lot, single-award, single-supplier GBP procedures with explicitly non-framework/non-DPS status; increases remain in the average. Unpublished data stays unknown. Awarded suppliers are winners, not all bidders.
Procedure terms
Contracting AuthorityGreat Western Hospitals NHS Foundation Trust
Procedure methodNot published
Procurement categoryNot published
Statuscomplete
Framework / DPSNot published
CompetitionNot published
Above thresholdNot published
Legal basisNot published
Tender period startsNot published
Clarification deadlineNot published
Electronic submissionNot published
Submission languagesNot published
Published10 Jul 2023, 08:54 BST
Last source update10 Jul 2023, 08:54 BST
Recurring procurementNot published
ClassificationPathology services
Delivery area
UK
OCIDocds-h6vhtk-03e01b
What is being bought
A contract for the provision of Histopathology reporting, Urology and Breast MDT
What changed
From the official release history
  1. Status changed to complete
    10 Jul 2023, 08:54 BST
  2. Official notice release published
    10 Jul 2023, 08:54 BST
  3. Buyer information updated
    10 Jul 2023, 08:54 BST
Lots and requirements (1)
Published by the contracting authority
  • Lot 1 · #1
    Individual lot title not published
    Status not published
    Published valueNot published
    A direct award to Poundbury Cancer Institute (PCI) for the supply of Histopathology reporting, Urology and Breast MDT
    Contract periodNot published
    EligibilityNot published
    Options / renewalNot published
Timeline
  1. Procedure published
    10 Jul 2023, 08:54 BST
  2. Award active
    Not published · Not published
  3. Contract active
    Signed 9 Jul 2023, 00:00 BST · £420,000
Commercial outcome and competition
Awards
POUNDBURY CANCER CENTRE LTD
Not published · Not published · active
Contracts
Contract
£420,000 · signed 9 Jul 2023, 00:00 BST · active
Bid statisticsNo aggregate bid statistics published
Buyer and organisations in this procedure

Great Western Hospitals NHS Foundation Trust

Contracting authority GB-FTS-161
View buyer profile

  • Great Western Hospitals NHS Foundation Trust
    buyer

    Marlborough Road, Swindon, UKK14, SN3 6BB
    Debbie.parin@nhs.net

  • POUNDBURY CANCER CENTRE LTD
    supplier

    Newborough House 3 Queen Mother Square, Dorchester, UKK2, DT1 3BJ

  • Salisbury Managed Procurement Services
    reviewBody
    reviewContactPoint

    Salisbury NHS Foundation Trust, Odstock Road, Salisbury, SP2 8BJ
Documents (0)
Official links; attachments are not copied
No data
No linked documents are published
Related procedures (0)
No data
No related procedures published
Planning and rationale
Planning budgetNot published
No-engagement rationaleNot published
Procedure rationaleGreat Western Hospitals NHS Foundation Trust (GWH) intends to award a contract under Regulation 32(2)(b)(ii), to Poundbury Cancer Institute (PCI) in respect of Histopathology reporting, Urology and Breast MDT, for a period of one year, with an option to extend for a further period of one year. This to maintain continuation of service delivery while the separate contract end dates for this requirement at GWH and Salisbury NHS Foundation Trust (SFT) are aligned and the collaborative requirement is re-tendered as a BSW Procurement Alliance collaborative contract, to ensure greater efficiency when procuring services. PCI is the incumbent supplier and the new contract will ensure that the current service is maintained until the re-tender is complete, without risk to patient care or the accumulation of cost and resource pressures. To award another supplier a temporary arrangement of this nature may result in the following:<br/><br/>Trust Turnaround Times and Patient Care: Variations in turnaround while new systems are set up. Currently PCI routes for reporting are established and consistent. Risking this could lead to increased Turnaround and delays to the diagnosis, and in turn treatment, of patients within the Trust <br/><br/>Packaging and Transport: new routes of transport for slides and blocks have to be set up. This will add extra pressure to the departments' sendaways team. Packaging requirements may also vary, leading to additional costs of purchase, and increased time to carry out alternative packaging requirements. <br/><br/>IT and Report Transcription: The reporting of cases by PCI is an established process, and the departments secretarial staff are familiar with the process of transcribing the received reports onto the LIMS. A new provider could lead to additional reporting processes, or access may be required to additional external IT systems, increasing the workload of the secretaries. <br/><br/>Additional Testing Requirements: A new provider may wish to introduce new tests (such as Immunohistochemical markers) not routinely performed within the department. This will increase the cost as these may have to be outsourced or will have to be worked up and verified in house, adding to the department's workload. Currently the requirements of PCI are known to the department and requesting additional work is an established process. <br/><br/>Documentation: Changing provider will result in numerous document updates that will add to the department's ongoing quality work. <br/><br/>Accreditation: UKAS, would have to be informed of any changes in provider, and any tests that they require that are not on our schedule would have to be reported as unaccredited tests.<br/><br/>GWH has reviewed the factors described and considers that for the technical reasons listed, awarding PCI is the only reasonable solution as it mitigates the risk of a detrimental effect on the service and the accumulation of preventable cost and resource pressures until the re-tender of the collaborative contract across the two Trusts. GWH will observe a 10 day standstill from the date of this notice before entering into a contract with Poundbury Cancer Institute (PCI).